104
Views
22
CrossRef citations to date
0
Altmetric
Original Research

Benralizumab does not impair antibody response to seasonal influenza vaccination in adolescent and young adult patients with moderate to severe asthma: results from the Phase IIIb ALIZE trial

, , , , , , & show all
Pages 181-192 | Published online: 16 Aug 2018

References